We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Citi Trends
CTRN
$605M
| $593K | ﹤0.01% |
27,611
-17,349
| -39% | -$324K |
|
802
International Paper
IP
$22B
| $588K | ﹤0.01% |
+12,470
| New | +$547K |
|
|
INVX
803
Innovex International
INVX
$1.97B
| $575K | ﹤0.01% |
5,268
-3,833
| -42% | -$412K |
|
804
Mercury Systems
MRCY
$6.52B
| $573K | ﹤0.01% |
50,507
+21,477
| +74% | +$268K |
|
|
WLB
805
DELISTED
Westmoreland Coal Company
WLB
| $572K | ﹤0.01% |
+15,773
| New | +$490K |
|
|
ESIO
806
DELISTED
Electro Scientific Industries
ESIO
| $570K | ﹤0.01% |
83,710
-2,619
| -3% | -$20.9K |
|
807
Allegion
ALLE
$14.4B
| $564K | ﹤0.01% |
9,949
-29,488
| -75% | -$1.55M |
|
808
Chord Energy
CHRD
$7.39B
| $564K | ﹤0.01% |
+10,097
| New | +$488K |
|
809
Lockheed Martin
LMT
$136B
| $564K | ﹤0.01% |
+3,510
| New | +$571K |
|
|
TI.A
810
DELISTED
Telecom Italia 10 Svg
TI.A
| $557K | ﹤0.01% |
56,524
-8,986
| -14% | -$86.4K |
|
811
Telephone and Data Systems
TDS
$3.75B
| $554K | ﹤0.01% |
+21,229
| New | +$563K |
|
812
Ampco-Pittsburgh
AP
$193M
| $551K | ﹤0.01% |
24,031
-6,318
| -21% | -$133K |
|
813
Fossil Group
FOSL
$318M
| $549K | ﹤0.01% |
+5,251
| New | +$561K |
|
814
Domino's
DPZ
$11.6B
| $545K | ﹤0.01% |
7,462
-154,910
| -95% | -$11.3M |
|
815
Equity Lifestyle Properties
ELS
$12.6B
| $545K | ﹤0.01% |
+24,696
| New | +$527K |
|
|
XCRA
816
DELISTED
Xcerra Corporation
XCRA
| $545K | ﹤0.01% |
59,839
-5,627
| -9% | -$51.7K |
|
|
WSTC
817
DELISTED
West Corporation
WSTC
| $543K | ﹤0.01% |
+20,268
| New | +$517K |
|
818
Broadridge
BR
$19B
| $531K | ﹤0.01% |
+12,761
| New | +$500K |
|
819
Integer Holdings
ITGR
$4.26B
| $522K | ﹤0.01% |
11,678
-2,211
| -16% | -$94.7K |
|
820
Murphy USA
MUSA
$9.61B
| $518K | ﹤0.01% |
+10,587
| New | +$491K |
|
|
GHDX
821
DELISTED
Genomic Health, Inc.
GHDX
| $515K | ﹤0.01% |
18,807
-20,882
| -53% | -$556K |
|
822
Citizens
CIA
$192M
| $513K | ﹤0.01% |
69,301
+35,819
| +107% | +$242K |
|
|
CSR
823
Centerspace
CSR
$952M
| $513K | ﹤0.01% |
+5,567
| New | +$494K |
|
|
AVG
824
DELISTED
AVG Technologies N.V.
AVG
| $511K | ﹤0.01% |
+25,408
| New | +$501K |
|
|
FCH
825
DELISTED
Felcor Lodging Trust
FCH
| $510K | ﹤0.01% |
48,487
+36,159
| +293% | +$348K |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.